The original version of this article inadvertently contained an error in the footnote of Table 1 (Patient  disposition) . A total of 16 patients discontinued prematurely due to treatment-related toxicity as shown correctly in the original table, but the details of these discontinuations shown in the footnote did not account for all 16 patients. The corrected footnote is as follows:
The original version of this article inadvertently contained an error in the footnote of Table 1 (Patient  disposition) . A total of 16 patients discontinued prematurely due to treatment-related toxicity as shown correctly in the original table, but the details of these discontinuations shown in the footnote did not account for all 16 patients. The corrected footnote is as follows:
Hypogammaglobulinemia (n=2); bacterial arthritis (n=1); idiopathic thrombocytopenic purpura (n=1); chronic active hepatitis (n=1); respiratory failure (n=1); allergy to arthropod bite (n=1); pneumonia (n=1); prostate cancer (n=1); bronchitis (n=1); cardiomyopathy (n=1); febrile neutropenia (n=1); salmonellosis (n=1); blood immunoglobulin M increased (n=1); lymphocyte count decreased (n=1); cerebrovascular accident (n=1: patient was not recorded as a discontinuation but last received study drug on 30 August 2007 and their AEs on/after that date were recorded as hypertensive crisis grade 1 and the grade 4 SAE of cerebrovascular accident).
